About the Ypsomed Group

The Ypsomed Group is a leading, independent developer and manufacturer of injection systems for self-medication and a renowned diabetes specialist with over 30 years of experience. Originating in 2003 from the famous company Disetronic, today Ypsomed offers insulin pumps and injection systems as well as pen needles for the treatment of diabetes, growth disorders, infertility and other therapeutic areas. Ypsomed is regarded as a leader in innovation and technology and is the preferred partner of pharmaceutical and biotech companies in the self-medication field.

Ypsomed headquarters are in Burgdorf, Switzerland, with several production sites in Switzerland and in the Czech Republic, and subsidiaries throughout Europe as well as leading, independent marketing partners throughout the world. The Ypsomed group has around 1200 employees.